Herpes simplex virus regulatory proteins VP16 and ICP0 counteract an innate intranuclear barrier to viral gene expression

Virology

Volumn 352, Issue 1, 2006, Pages 237-252

  Hancock, Meaghan H ^a   Corcoran, Jennifer A ^a   Smiley, James R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cell fusion; Herpes simplex virus; ICP0; Innate immunity; Reovirus p14; Somatic cell hybrid; VP16

Indexed keywords

ICP0 PROTEIN; PROTEIN VP16; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HETEROKARYON; HUMAN; HUMAN CELL; HYBRID CELL; INNATE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; VIRUS GENE;

CELL LINE; CELL LINE, TUMOR; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX VIRUS PROTEIN VMW65; HUMANS; HYBRID CELLS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, NATURAL; SIMPLEXVIRUS; UBIQUITIN-PROTEIN LIGASES; VIRAL PROTEINS; VIRUS REPLICATION;

SIMPLEXVIRUS;

EID: 33746580534     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.021     Document Type: Article

References (98)

1. Ace C.I., McKee T.A., Ryan J.M., Cameron J.M., and Preston C.M. Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. J. Virol. 63 5 (1989) 2260-2269
2. Benedict C.A., Norris P.S., and Ware C.F. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3 11 (2002) 1013-1018
3. Boutell C., Sadis S., and Everett R.D. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76 2 (2002) 841-850
4. Cai W., and Schaffer P.A. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66 5 (1992) 2904-2915
5. Cai W., Astor T.L., Liptak L.M., Cho C., Coen D.M., and Schaffer P.A. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J. Virol. 67 12 (1993) 7501-7512
6. Chee A.V., Lopez P., Pandolfi P.P., and Roizman B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77 12 (2003) 7101-7105
7. Chelbi-Alix M.K., and de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18 4 (1999) 935-941
8. Chou J., Chen J.J., Gross M., and Roizman B. Association of a M (r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5-mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. U.S.A. 92 23 (1995) 10516-10520
9. Corcoran J.A., and Duncan R. Reptilian reovirus utilizes a small type III protein with an external myristylated amino terminus to mediate cell-cell fusion. J. Virol. 78 8 (2004) 4342-4351
10. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., and Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U.S.A. 99 18 (2002) 11914-11919
11. Cunningham C., and Davison A.J. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197 1 (1993) 116-124
12. Dellaire G., and Bazett-Jones D.P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26 9 (2004) 963-977
13. Eidson K.M., Hobbs W.E., Manning B.J., Carlson P., and DeLuca N.A. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76 5 (2002) 2180-2191
14. Everett R.D. Activation of cellular promoters during herpes simplex virus infection of biochemically transformed cells. EMBO J. 4 (1985) 1973-1980
15. Everett R.D. Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J. Gen. Virol. 70 Pt. 5 (1989) 1185-1202
16. Everett R.D. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22 8 (2000) 761-770
17. Everett R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20 49 (2001) 7266-7273
18. Everett R.D. Interactions between DNA viruses, ND10 and the DNA damage response. Cell. Microbiol. 8 3 (2006) 365-374
19. Everett R.D., and Maul G.G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13 21 (1994) 5062-5069
20. Everett R., O'Hare P., O'Rourke D., Barlow P., and Orr A. Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. J. Virol. 69 11 (1995) 7339-7344
21. Everett R.D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., and Parkinson J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72 8 (1998) 6581-6591
22. Everett R.D., Orr A., and Preston C.M. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J. 17 24 (1998) 7161-7169
23. Everett R.D., Earnshaw W.C., Findlay J., and Lomonte P. Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J. 18 6 (1999) 1526-1538
24. Everett R.D., Boutell C., and Orr A. Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J. Virol. 78 4 (2004) 1763-1774
25. Everett R.D., Sourvinos G., Leiper C., Clements J.B., and Orr A. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J. Virol. 78 4 (2004) 1903-1917
26. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W.A., and Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66 11 (1992) 6489-6495
27. Gelman I.H., and Silverstein S. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 82 16 (1985) 5265-5269
28. Goff S.P. Retrovirus restriction factors. Mol. Cell 16 6 (2004) 849-859
29. Gongora C., David G., Pintard L., Tissot C., Hua T.D., Dejean A., and Mechti N. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272 31 (1997) 19457-19463
30. Goodbourn S., Didcock L., and Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 Pt. 10 (2000) 2341-2364
31. Grotzinger T., Sternsdorf T., Jensen K., and Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238 2 (1996) 554-560
32. Gu H., Liang Y., Mandel G., and Roizman B. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl. Acad. Sci. U.S.A. 102 21 (2005) 7571-7576
33. Hagglund R., Van Sant C., Lopez P., and Roizman B. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U.S.A. 99 2 (2002) 631-636
34. Halford W.P., Kemp C.D., Isler J.A., Davido D.J., and Schaffer P.A. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J. Virol. 75 13 (2001) 6143-6153
35. Harris R.A., and Preston C.M. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. J. Gen. Virol. 72 Pt. 4 (1991) 907-913
36. Harris R.A., Everett R.D., Zhu X.X., Silverstein S., and Preston C.M. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J. Virol. 63 8 (1989) 3513-3515
37. Herrera F.J., and Triezenberg S.J. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J. Virol. 78 18 (2004) 9689-9696
38. Hobbs W.E., Brough D.E., Kovesdi I., and DeLuca N.A. Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. J. Virol. 75 7 (2001) 3391-3403
39. Hofmann T.G., and Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10 12 (2003) 1290-1299
40. Jackson S.A., and DeLuca N.A. Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc. Natl. Acad. Sci. U.S.A. 100 13 (2003) 7871-7876
41. Jamieson D.R., Robinson L.H., Daksis J.I., Nicholl M.J., and Preston C.M. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J. Gen. Virol. 76 Pt. 6 (1995) 1417-1431
42. Jordan R., and Schaffer P. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J. Virol. 71 (1997) 6850-6862
43. Kawai T., and Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17 4 (2005) 338-344
44. Kent J.R., Zeng P.Y., Atanasiu D., Gardner J., Fraser N.W., and Berger S.L. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J. Virol. 78 18 (2004) 10178-10186
45. Klemm R.D., Goodrich J.A., Zhou S., and Tjian R. Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 92 13 (1995) 5788-5792
46. Knipe D.M., Senechek D., Rice S.A., and Smith J.L. Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J. Virol. 61 2 (1987) 276-284
47. Kobayashi N., Horn P.J., Sullivan S.M., Triezenberg S.J., Boyer T.G., and Berk A.J. DA-complex assembly activity required for VP16C transcriptional activation. Mol. Cell. Biol. 18 7 (1998) 4023-4031
48. Lees-Miller S.P., Long M.C., Kilvert M.A., Lam V., Rice S.A., and Spencer C.A. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J. Virol. 70 11 (1996) 7471-7477
49. Leinbach S.S., and Summers W.C. The structure of herpes simplex virus type 1 DNA as probed by microccal nuclease digestion. J. Gen. Virol. 51 (1980) 45-59
50. Lin H.K., Bergmann S., and Pandolfi P.P. Cytoplasmic PML function in TGF-beta signalling. Nature 431 7005 (2004) 205-211
51. Lomonte P., Sullivan K.F., and Everett R.D. Degradation of nucleosome-associated centromeric histone H3-like protein CENP-A induced by herpes simplex virus type 1 protein ICP0. J. Biol. Chem. 276 8 (2001) 5829-5835
52. Lomonte P., Thomas J., Texier P., Caron C., Khochbin S., and Epstein A.L. Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J. Virol. 78 13 (2004) 6744-6757
53. Loppin B., Bonnefoy E., Anselme C., Laurencon A., Karr T.L., and Couble P. The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature 437 7063 (2005) 1386-1390
54. Loyola A., and Almouzni G. Histone chaperones, a supporting role in the limelight. Biochim. Biophys. Acta 1677 1-3 (2004) 3-11
55. Madani N., and Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72 12 (1998) 10251-10255
56. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., and Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114 1 (2003) 21-31
57. Maul G.G. Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays 20 (1998) 660-667
58. Memedula S., and Belmont A.S. Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16. Curr. Biol. 13 3 (2003) 241-246
59. Minaker R.L., Mossman K.L., and Smiley J.R. Functional inaccessibility of quiescent herpes simplex virus genomes. Virol. J. 2 1 (2005) 85
60. Mittler G., Stuhler T., Santolin L., Uhlmann T., Kremmer E., Lottspeich F., Berti L., and Meisterernst M. A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J. 22 24 (2003) 6494-6504
61. Mossman K.L., and Smiley J.R. Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0. J. Virol. 73 12 (1999) 9726-9733
62. Mossman K.L., and Smiley J.R. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76 4 (2002) 1995-1998
63. Mossman K.L., Saffran H.A., and Smiley J.R. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74 4 (2000) 2052-2056
64. Muggeridge M.I., and Fraser N.W. Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system. J. Virol. 59 (1986) 764-767
65. Munk C., Brandt S.M., Lucero G., and Landau N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U.S.A. 99 21 (2002) 13843-13848
66. Netea M.G., van der Graaf C., Van der Meer J.W., and Kullberg B.J. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75 5 (2004) 749-755
67. Nisole S., Stoye J.P., and Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev., Microbiol. 3 10 (2005) 799-808
68. O'Hare P., and Gooding C.R. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell 52 (1988) 435-445
69. O'Hare P., and Hayward G.S. Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J. Virol. 56 3 (1985) 723-733
70. Parkinson J., Lees-Miller S.P., and Everett R.D. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 73 1 (1999) 650-657
71. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., Higashimoto Y., Appella E., Minucci S., Pandolfi P.P., and Pelicci P.G. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406 6792 (2000) 207-210
72. Preston C.M. Repression of viral transcription during herpes simplex virus latency. J. Gen. Virol. 81 Pt. 1 (2000) 1-19
73. Preston C.M., and Nicholl M.J. Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J. Virol. 71 10 (1997) 7807-7813
74. Preston C.M., Frame M.C., and Campbell M.E. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell 52 3 (1988) 425-434
75. Quinlan M.P., and Knipe D.M. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 5 (1985) 957-963
76. Ray-Gallet D., Quivy J.P., Scamps C., Martini E.M., Lipinski M., and Almouzni G. HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol. Cell 9 5 (2002) 1091-1100
77. Roizman B., and Knipe D.M. Herpes simplex viruses and their replication. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Strauss S.E. (Eds). Field's Virology. 4th ed. (2001), Lippincott, Williams and Wilkins, Philadelphia 2381-2398
78. Russell J., Stow N.D., Stow E.C., and Preston C.M. Herpes simplex virus genes involved in latency in vitro. J. Gen. Virol. 68 Pt. 12 (1987) 3009-3018
79. Samaniego L.A., Wu N., and DeLuca N.A. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71 6 (1997) 4614-4625
80. Samaniego L.A., Neiderhiser L., and DeLuca N.A. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72 4 (1998) 3307-3320
81. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 6898 (2002) 646-650
82. Simon J.H., Gaddis N.C., Fouchier R.A., and Malim M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4 12 (1998) 1397-1400
83. Smiley J.R., and Duncan J. Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the in1814 linker insertion mutation. J. Virol. 71 8 (1997) 6191-6193
84. Stadler M., Chelbi-Alix M.K., Koken M.H., Venturini L., Lee C., Saib A., Quignon F., Pelicano L., Guillemin M.C., Schindler C., et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11 12 (1995) 2565-2573
85. Stern S., Tanaka M., and Herr W. The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature 341 6243 (1989) 624-630
86. Stow N.D., and Stow E.C. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67 Pt. 12 (1986) 2571-2585
87. Strebel K., Daugherty D., Clouse K., Cohen D., Folks T., and Martin M.A. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328 6132 (1987) 728-730
88. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 6977 (2004) 848-853
89. Triezenberg S.J., Kingsbury R.C., and McKnight S.L. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2 (1988) 718-729
90. Uesugi M., Nyanguile O., Lu H., Levine A.J., and Verdine G.L. Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science 277 5330 (1997) 1310-1313
91. Voinnet O. Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev., Genet. 6 3 (2005) 206-220
92. von Schwedler U., Song J., Aiken C., and Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67 8 (1993) 4945-4955
93. Wang F., Ma Y., Barrett J.W., Gao X., Loh J., Barton E., Virgin H.W., and McFadden G. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat. Immunol. 5 12 (2004) 1266-1274
94. Weinheimer S.P., Boyd B.A., Durham S.K., Resnick J.L., and O'Boyle D.R. Deletion of the VP16 open reading frame of herpes simplex virus type 1. J. Virol. 66 1 (1992) 258-269
95. Xiao P., and Capone J.P. A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1. Mol. Cell. Biol. 10 9 (1990) 4974-4977
96. Xiao H., Pearson A., Coulombe B., Truant R., Zhang S., Regier J.L., Triezenberg S.J., Reinberg D., Flores O., Ingles C.J., et al. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14 10 (1994) 7013-7024
97. Yao F., and Schaffer P.A. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J. Virol. 69 10 (1995) 6249-6258
98. Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M., Erzberger J.P., Serebriiskii I.G., Canutescu A.A., Dunbrack R.L., Pehrson J.R., Berger J.M., Kaufman P.D., and Adams P.D. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8 1 (2005) 19-30